Novo Nordisk sued in Denmark for alleged market manipulation - media
Share:
COPENHAGEN (Reuters) - Danish insulin-maker Novo Nordisk has been sued by investors demanding 11.8 billion Danish crowns (1.5 billion pounds) in compensation for the company's alleged market manipulation, Danish daily Borsen reported on Friday."Novo has provided and disseminated inaccurate, incomplete and misleading information and failed to disclose internal knowledge and this constitutes price manipulation," the investors' lawyers said in a statement according to Borsen.According to the..